ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Corticosteroids in Prevention of Facial Palsy After Cranial Base Surgery

This study is currently recruiting participants.
Verified by Assistance Publique - Hôpitaux de Paris, September 2007

Sponsored by: Assistance Publique - Hôpitaux de Paris
Information provided by: Assistance Publique - Hôpitaux de Paris
ClinicalTrials.gov Identifier: NCT00438087
  Purpose

Facial palsy after surgical removal of cranial base tumors adherent to the nerve can partly be explained by inflammation.


Condition Intervention Phase
Facial Palsy
Drug: methylprednisolone
Phase III

Genetics Home Reference related topics:   neurofibromatosis type 2   

MedlinePlus related topics:   Bell's Palsy    Benign Tumors    Paralysis   

ChemIDplus related topics:   Methylprednisolone    Corticosteroids   

U.S. FDA Resources

Study Type:   Interventional
Study Design:   Prevention, Randomized, Double Blind (Subject, Investigator), Placebo Control, Parallel Assignment, Safety/Efficacy Study
Official Title:   Assessment of Corticosteroid Effect in the Prevention of Facial Palsy After Cerebella-Pontine Angle Surgery

Further study details as provided by Assistance Publique - Hôpitaux de Paris:

Primary Outcome Measures:
  • Assessment of the facial function at 8 days postoperative [ Time Frame: at 8 days postoperative ] [ Designated as safety issue: Yes ]

Secondary Outcome Measures:
  • Assessment of the facial function at 1 day postoperative [ Time Frame: at 1 day postoperative ] [ Designated as safety issue: Yes ]

Estimated Enrollment:   380
Study Start Date:   March 2007
Estimated Study Completion Date:   May 2009
Estimated Primary Completion Date:   May 2009 (Final data collection date for primary outcome measure)

Arms Assigned Interventions
2: Placebo Comparator
placebo versus methylprednisolone
Drug: methylprednisolone
methylprednisolone administrated intra and post operatively
1: Experimental
placebo versus methylprednisolone
Drug: methylprednisolone
methylprednisolone administrated intra and post operatively

Show detailed description  Show Detailed Description

  Eligibility
Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Criteria

Inclusion Criteria:

  • adults patients
  • surgery of base crane tumors
  • accept to participate
  • having health insurance

Exclusion Criteria:

  • pregnant woman
  • children
  • known allergy to steroids
  • preoperative facial palsy of grade >2
  Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00438087

Contacts
Contact: Alexis BOZORG GRAYELI, MD,PhD     +33 (0)-1 40 87 56 29     alexis.bozorg-grayeli@bjn.aphp.fr    

Locations
France
Assistance Publique Hopitaux De Paris     Recruiting
      CLICHY, France
      Contact: Alexis BOZORG GRAYELLI, MD,PhD     +33(0)- 1 40 87 56 29     alexis.bozorg-grayeli@bjn.aphp.fr    

Sponsors and Collaborators
Assistance Publique - Hôpitaux de Paris

Investigators
Principal Investigator:     Alexis BOZORG GRAYELI, MD,PhD     Assistance Publique - Hôpitaux de Paris    
  More Information


Responsible Party:   Department Clinical Research of Developpement ( Cécile KEDZIA )
Study ID Numbers:   P051072
First Received:   February 9, 2007
Last Updated:   April 25, 2008
ClinicalTrials.gov Identifier:   NCT00438087
Health Authority:   France: Ministry of Health

Keywords provided by Assistance Publique - Hôpitaux de Paris:
Facial palsy  
Vestibular schwannoma  
Anti-inflammatory drugs  
Post surgery of vestibular schwannoma  
or of cranial base tumors  

Study placed in the following topic categories:
Mouth Diseases
Neuroma, Acoustic
Facies
Methylprednisolone
Bell Palsy
Methylprednisolone acetate
Neurilemmoma
Prednisolone acetate
Acoustic neuroma
Bell's palsy
Facial Paralysis
Herpesviridae Infections
Paralysis
Virus Diseases
Signs and Symptoms
Facial Nerve Diseases
Prednisolone
Neurologic Manifestations
DNA Virus Infections
Stomatognathic Diseases
Methylprednisolone Hemisuccinate

Additional relevant MeSH terms:
Anti-Inflammatory Agents
Disease Attributes
Antineoplastic Agents, Hormonal
Antineoplastic Agents
Nervous System Diseases
Physiological Effects of Drugs
Hormones, Hormone Substitutes, and Hormone Antagonists
Gastrointestinal Agents
Antiemetics
Hormones
Glucocorticoids
Protective Agents
Neuroprotective Agents
Pharmacologic Actions
Pathologic Processes
Autonomic Agents
Therapeutic Uses
Cranial Nerve Diseases
Peripheral Nervous System Agents
Central Nervous System Agents

ClinicalTrials.gov processed this record on October 17, 2008




Links to all studies - primarily for crawlers